Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Fall 2013 - Innovation
Download Issue
Share
Up Front
Publisher's Corner
Innovation: The Path of Progress
By Patrick M. Schmidt
Features
Increasing the Role of Pharmacists in Patient Care
By
Amy Scanlin, MS
Myths and Facts: Celiac Disease
By
Ronale Tucker Rhodes, MS
Medical Informatics
By
Amy Scanlin, MS
Superbugs: Reducing the Serious Threat of Hospital-Acquired Infections
By
Jim Trageser
From Here to Immortality: Anti-Aging Medicine
By
Trudie Mitschang
Frontrunner Solutions in Genetic Testing Diagnostics
By
Trudie Mitschang
BioTrends Watch
Washington Report
Health Insurance Marketplace Tools Unveiled
HHS Launches Video Contest with Young Invincibles
NGA Publishes Report on Maternal and Child Health Services Reforms
HHS Grants $32M to Enroll Children in Health Insurance
Health Centers Given $150M to Help Uninsured Americans Gain Coverage
Industry News
Novavax Inc. Vaccine Update
PSA Launched to Raise Awareness for MMN
Quadrivalent VLP Vaccine Achieves Phase II Trial Endpoints
CDC Updates VariZIG Use Recommendations
Study Reveals Barriers to Flu Vaccine for Pregnant Women
New Vial Size Approved for CSL Behring's Hizentra
New Vaccine Barcodes Enhance Safety
FDA Approves Two New Quadrivalent Vaccines
FDA Launches Supply Chain Pilot Program
New Vaccine Developed for Food and Mouth Disease
BioFocus
Industry Insight
Man Versus Flu: The Search for a Universal Flu Vaccine
By Keith Berman, MPH, MBA
Patient Profile
PIDD: A Patient's Perspective
By Trudie Mitschang
Physician Profile
PIDD: A Physician's Perspective
By Trudie Mitschang
BioSources
BioResearch
Intravenous Immunoglobulin (Privigen) Effective, Well-Tolerated as Therapy for Chronic Inflammatory Demyelinating Polyneuropathy
Immunogenicity, Reactogenicity and Safety of Quadrivalent and Trivalent Influenza Vaccines
Safety and Efficacy of Investigational Single-Chain Recombinant Factor VIII Examined in Preclinical Studies